MarketPeel
Insider Trading Intelligence
FL

Fairmount Healthcare Fund II Gp Llc

VRDN
DIRECTOR · VIRIDIAN THERAPEUTICS, INC.DE · CIK 0001830382
FILING MIX · LIFETIME73%/27%
BUYS
11
SELLS
4
TOTAL VALUE
$130.17M
COMPANIES
1
ACTIVE SINCE
Sep 2021
HOLDINGS NOW
5,090,928
AVG SELL PX
TRADE KIND
SHOWING 15 / 15
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 8 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Fairmount Healthcare Fund II Gp Llc, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+83.33%+9.07%+0.27%+8.80%+3.07%
14d6+66.67%+10.09%-0.77%+12.83%+4.87%
30d6+50.00%+9.53%+0.05%+9.48%+4.13%
60d6(1 pending)+60.00%+15.95%+2.22%+13.73%+0.32%
90d6(1 pending)+60.00%+11.49%+2.53%+8.96%+6.50%
180d6(1 pending)+40.00%+3.19%+3.99%-0.80%-24.61%
1y6(2 pending)+25.00%+6.41%+9.18%-2.76%-26.45%
2y6(3 pending)+66.67%+18.09%+26.83%-8.74%+17.43%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
VRDN · 5,090,928 shares · as of May 11, 2026
01,272,7322,545,4643,818,1965,090,92820222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 11 buys / 4 sellsCOVERAGE · 20 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
PURCHASE
1,176,470$17.00$20.00M5,090,928May 11, 2026May 13, 2026View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
PURCHASE
454,545$22.00$10.00M3,914,458Oct 23, 2025Oct 27, 2025View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
PURCHASE
12,500$12.31$153.9K3,459,913Jun 10, 2025Jun 11, 2025View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
SALE
12,5000Jun 10, 2025Jun 11, 2025View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
PURCHASE
1,600$7.80$12.5K3,447,413Jun 9, 2025Jun 11, 2025View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
SALE
1,6000Jun 9, 2025Jun 11, 2025View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
PURCHASE
1,600,000$18.75$30.00M3,445,813Sep 13, 2024Sep 17, 2024View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
SALE
5,8590Mar 28, 2024Apr 1, 2024View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
PURCHASE
21,999133,191Mar 28, 2024Apr 1, 2024View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
PURCHASE
5,8591,845,813Mar 28, 2024Apr 1, 2024View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
SALE
21,9990Mar 28, 2024Apr 1, 2024View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
PURCHASE
476,190$21.00$10.00M1,839,954Jan 22, 2024Jan 24, 2024View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
PURCHASEGRANT
Stock grant
48,463$825.37$40.00M48,463Oct 30, 2023Nov 1, 2023View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
PURCHASE
425,531$23.50$10.00M1,363,764Aug 17, 2022Aug 19, 2022View →
VRDN
VIRIDIAN THERAPEUTICS, INC.DE
PURCHASE
909,000$11.00$10.00M938,233Sep 21, 2021Sep 23, 2021View →
Other insiders · VRDN
Loading peer insiders…
About this filer
CIK 0001830382
ROLE
Director
PRIMARY
VRDN
COMPANIES
1
ACTIVE SINCE
Sep 2021
MARKETPEEL · /INSIDER/0001830382DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback